AORTIC PSEUDOANEURYSM

AORTIC PSEUDOANEURYSM was reported 59 times

These drug classes are most commonly taken by patients reporting AORTIC PSEUDOANEURYSM:

# Drug Count
0 Corticosteroid [EPC] 17
1 Folate Analog Metabolic Inhibitor [EPC] 15
2 Tumor Necrosis Factor Blocker [EPC] 14
3 Interleukin-6 Receptor Antagonist [EPC] 10
4 Alkylating Drug [EPC] 7
5 Nonsteroidal Anti-inflammatory Drug [EPC] 7
6 Platelet Aggregation Inhibitor [EPC] 7
7 Antimetabolite Immunosuppressant [EPC] 6
8 Human Immunoglobulin G [EPC] 6
9 Purine Antimetabolite [EPC] 6
10 Factor Xa Inhibitor [EPC] 5
11 Glycopeptide Antibacterial [EPC] 5
12 Kinase Inhibitor [EPC] 5
13 Azole Antifungal [EPC] 3
14 Penem Antibacterial [EPC] 3
15 Antirheumatic Agent [EPC] 2
16 Bispecific CD20-directed CD3 T Cell Engager [EPC] 2
17 Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] 2
18 Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC] 2
19 Oxazolidinone Antibacterial [EPC] 2
20 mTOR Inhibitor Immunosuppressant [EPC] 2
21 Acetylcholine Release Inhibitor [EPC] 1
22 Androgen Receptor Inhibitor [EPC] 1
23 Antidote [EPC] 1
24 Antidote for Acetaminophen Overdose [EPC] 1
25 Autologous Cellular Immunotherapy [EPC] 1
26 CD20-directed Cytolytic Antibody [EPC] 1
27 Calcium Channel Blocker [EPC] 1
28 Complement Inhibitor [EPC] 1
29 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
30 Dihydropyridine Calcium Channel Blocker [EPC] 1
31 Fluoroquinolone Antibacterial [EPC] 1
32 HMG-CoA Reductase Inhibitor [EPC] 1
33 Janus Kinase Inhibitor [EPC] 1
34 Mucolytic [EPC] 1
35 Neuromuscular Blocker [EPC] 1
36 Nucleoside Metabolic Inhibitor [EPC] 1
37 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
38 Prostacycline Vasodilator [EPC] 1
39 Proton Pump Inhibitor [EPC] 1
40 Rifamycin Antibacterial [EPC] 1